(MENAFN – GlobeNewsWire – Nasdaq)
Westford, United States, April 6, 2023 (GLOBE NEWSWIRE) — The predicted era (2022-2030) is expected to succeed in the plasma cure market priced at $824. 51 million at a CAGR of 15. 18%, and the expansion is driven by the rise of viral diseases such as COVID-19, protective device projects and financing, awareness and research, and collaboration and partnerships. SkyQuest reports an increase in the use of the convalescent plasma cure as a remedy for COVID-19, with the United States administering more than 600,000 doses.
Based on findings from SkyQuest’s most recent studies, plasma treatment has been shown to be effective in treating certain autoimmune diseases, such as idiopathic thrombocytopenic purpura (ITP), with a fortune rate of up to 80% in some cases. In addition, the report highlights global demand for plasma-derived treatments is expected to exceed six hundred metric tons through 2025, up from 270 metric tons in 2018, due to aging population and increased prevalence of chronic diseases.
Get an example of this report:
Explore the table of contents in intensity in the “Plasma Therapy Market”
In the new times, plasma cure has become a comprehensive remedy technique in the healthcare industry, especially for COVID-19. Plasma from recovered patients is used to treat those who are still infected, and the effects have been promising in the treatment of critically ill patients. Therefore, the demand for plasma cure has increased globally. In addition, researchers are exploring the possibility of curing with plasma to treat other diseases, such as cancer and autoimmune diseases.
Major Players in the Plasma Treatment Market
Infectious diseases will boost sales due to increasing prevalence of infectious diseases, such as COVID-19
According to a recent analysis, the infectious diseases segment has emerged as a significant contributor to the immediate progression of the plasma treatment market in 2021. This trend is expected to continue from 2022 to 2030 due to the increasing prevalence of infectious diseases, such as COVID-19. 19, and the increasing prevalence of autoimmune diseases, such as sclerosis and rheumatoid arthritis. Recently, researchers in China effectively used plasma treatment to treat a patient with severe idiopathic thrombocytopenic purpura (ITP). It can cause bleeding and bruising.
Studies of the studies indicate that North America is poised to become a dominant player in the plasma cure market from 2022 to 2030. SkyQuest has forecast that the region will grow at a CAGR of 9. 82% during the forecast period. The increasing prevalence of chronic diseases, favorable reimbursement policies, and increased investment in studies and progression activities are behind this expansion in the region. Recently, the U. S. National Institutes of Health (NIH) announced a new clinical trial to compare the protection and efficacy of convalescent plasma in the remedy of other people with mild to moderate COVID-19. The trial is expected to recruit up to 1,000 participants at various sites across the country.
Explore the report summary and full table of contents (ToC):
The platelet-rich plasma segment will show expansion due to its effectiveness in selling tissue regeneration and wound healing.
From 2022 to 2030, the platelet-rich plasma parts segment is expected to remain the leading focus in the plasma cure market, according to a recent analysis. PRP has already established its dominance in 2021 due to its effectiveness in selling tissue regeneration and wound healing. , making the remedy safer and more effective. Its application in various medical fields, including orthopedics, dentistry and dermatology, has contributed to its generalization. In addition, a recent study published in the Journal of Clinical Medicine showed that PRP cures well reduces hair loss. in patients with androgenetic alopecia. The study showed a statistically significant increase in hair density in patients who received PRP treatment compared to those who did not.
The Asia Pacific region has also become a significant force in the plasma treatment market and is poised to maintain its leading position through 2030. SkyQuest has forecast significant expansion in the plasma treatment market for the Asia Pacific region, with a projected CAGR of 10. 97% in the forecast period. This expansion can be attributed to the increasing prevalence of chronic diseases and the expansion of the geriatric population in the region.
Recently, a thorough investigation of the major players in the Plasma Therapy market was conducted in a report. The report encompasses facets that aggregate collaborations, mergers, policies and cutting-edge business strategies, and offers valuable insights into key trends and advancements in the market. In addition, the report examines the market share of the primary segments and presents a detailed geographical research. Finally, the report sheds light on the major industry players and their efforts to expand cutting-edge responses to meet the growing demand.
Key Advancements in the Plasma Treatment Market
Talk to the analyst for your needs:
Key Questions Answered in the Plasma Therapy Market Report
Related in the SkyQuest library:
Global market for antibodies and reagents
Global Targeted Therapies Market
Global IVD Quality Control Market
Global Microbubble/Ultrasonic Contrast Agents Market
Global Yeast Extracts Market for Animal Feed
About us:
SkyQuest Technology is a leading expansion consulting firm providing market intelligence, merchandising and generation services. It has more than 450 satisfied consumers worldwide.
ADDRESS:
1 Apache Way, Westford, Massachusetts 01886
Telephone:
United States ( 1) 617-230-0741
Email:
Twitter de LinkedIn
HOMBREFN06042023004107003653ID1105960029
Keywords
comment
Category
Date